Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094781 · ClinicalTrials.gov registry record · Phase 1
Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males
A Phase 1 study of Nutritional Status, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02094781 is a Phase 1 study of Nutritional Status that has completed, run by GlaxoSmithKline. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02094781, a Phase 1 study of Nutritional Status, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper and lower body strength.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whey protein and creatine supplement
- DIETARY_SUPPLEMENT Whey protein only supplement
Study Locations (1)
Florida
- GSK Investigational Site - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02094781
The ClinicalTrials.gov registry entry for NCT02094781 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nutritional Status appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02094781 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02094781 about?
NCT02094781 is a clinical study titled "Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males". The purpose of this study was to evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper and lower body strength.
What is the current status of trial NCT02094781?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2013-12. Estimated completion is 2014-09.
What conditions does trial NCT02094781 study?
This clinical trial studies the following conditions: Nutritional Status.
What interventions are being tested in trial NCT02094781?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whey protein and creatine supplement (DIETARY_SUPPLEMENT), Whey protein only supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02094781?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02094781 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nutritional Status
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.